View More
American Gastroenterological Association (AGA)
4930 Del Ray Avenue
Bethesda, MD 20814
Phone: (301) 654-2055
Fax: (301) 654-5920
Email: member@gastro.org
Unlocked slides from Brent Tetri, MD, and CCO: impact of NASH and the interplay with diabetes, obesity, and cardiovascular disease
Brent A. Neuschwander-Tetri, MD
Released: February 3, 2021
Expert commentary discussing the complex interplay among NASH, obesity, and diabetes from Clinical Care Options (CCO)
Brent A. Neuschwander-Tetri, MD
Physicians:
maximum of 0.25 AMA PRA Category 1 Credits™
Registered Nurses:
0.25 Nursing contact hours
Pharmacists:
0.25 contact hours (0.025 CEUs)
Released: January 29, 2021
Expired:
January 28, 2022
Stephen A. Harrison, MD, COL (Ret.), FAASLD, explains how to interpret endpoints used in NASH studies so you can evaluate emerging treatments.
Stephen A. Harrison, MD, COL (Ret.), FAASLD
Released: March 29, 2019
Kenneth Cusi, MD, FACP, FACE, explains how to interpret endpoints used in NASH studies so you can evaluate emerging treatments.
Kenneth Cusi, MD, FACP, FACE
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.